|
Volumn 45, Issue 11, 2010, Pages 4963-4967
|
Design, synthesis and biological evaluation of 1,3,4-oxadiazole derivatives
|
Author keywords
1,3,4 Oxadiazole; 3D QSAR; Antimicrobial activity; kNN MFA
|
Indexed keywords
1,3,4 OXADIAZOLE DERIVATIVE;
2 (5 PHENYL 1,3,4 OXADIAZOL 2 YL)PHENOL;
2 (5 SULFANYL 1,3,4 OXADIAZOL 2 YL)PHENOL;
2 (5 SULFANYL 1,3,4 OXADIAZOL 2 YL)PHENYLACETATE;
2 [5 (2 METHYLPHENYL) 1,3,4 OXADIAZOL 2 YL]PHENOL;
2 [5 (4 METHYLPHENYL) 1,3,4 OXADIAZOL 2 YL]PHENOL;
2 [5 (NAPHTHALEN 2 YLMETHYL) 1,3,4 OXADIAZOL 2 YL];
3 (5 PHENYL 1,3,4 OXADIAZOL 2 YL)PYRIDINE;
5 (4 METHYLPHENYL) 1, 3, 4 OXADIAZOLE 2 THIOL;
5 (PYRIDIN 3 YL) 1,3,4 OXADIAZOLE 2 THIOL;
5 PHENYL 1,3,4 OXADIAZOLE 2 THIOL;
CARBON DISULFIDE;
UNCLASSIFIED DRUG;
ANTIMICROBIAL ACTIVITY;
ARTICLE;
CLINICAL EVALUATION;
DRUG DESIGN;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ESCHERICHIA COLI;
K NEAREST NEIGHBOR;
NONHUMAN;
QUANTITATIVE STRUCTURE ACTIVITY RELATION;
STAPHYLOCOCCUS AUREUS;
STAPHYLOCOCCUS EPIDERMIDIS;
ANTI-BACTERIAL AGENTS;
DRUG DESIGN;
MAGNETIC RESONANCE SPECTROSCOPY;
MICROBIAL SENSITIVITY TESTS;
OXADIAZOLES;
QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;
SPECTROSCOPY, FOURIER TRANSFORM INFRARED;
STAPHYLOCOCCUS AUREUS;
STAPHYLOCOCCUS EPIDERMIDIS;
|
EID: 77957841534
PISSN: 02235234
EISSN: 17683254
Source Type: Journal
DOI: 10.1016/j.ejmech.2010.08.003 Document Type: Article |
Times cited : (145)
|
References (37)
|